Screening and characterization of microbial inhibitors against eukaryotic protein phosphatases (PP1 and PP2A)

Journal of Applied Microbiology

Volumn 102, Issue 3, 2007, Pages 680-692

  Ong, S M ^a   Voo, L Y C ^a   Lai, N S ^a   Stark, M J R ^b   Ho, C C ^a  

^a UNIVERSITI MALAYSIA SABAH   (Malaysia)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Inhibitor; Penicillium; Protein phosphatase; Sabah; Streptomyces

Indexed keywords

ACETONE; BACTERIA; FORESTRY; PHOSPHATASES; SOIL TESTING; SOILS; STRAIN; YEAST;

EUKARYOTIC PROTEINS; FOREST SOILS; INHIBITOR; MICRO-FUNGI; PENICILLIUM; POTENTIAL PROTEINS; PROTEIN PHOSPHATASE; PROTEIN PHOSPHATASE-1; SABAH; STREPTOMYCES;

MAMMALS;

ACETONE; H 7520; H 9318; H 9978; PENICILLIN DERIVATIVE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIBIOTICS; BACTERIUM; ENZYME ACTIVITY; FOREST SOIL; FUNGUS; IDENTIFICATION METHOD; INHIBITOR; PHOSPHATASE; PROTEIN; SOIL MICROORGANISM;

ACTINOBACTERIA; ARTICLE; DRUG SCREENING; ENZYME INHIBITION; FRACTIONATION; FUNGAL STRAIN; FUNGUS; NONHUMAN; PENICILLIUM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STREPTOMYCES;

ASIA; EAST MALAYSIA; EURASIA; MALAYSIA; SABAH; SOUTHEAST ASIA;

ACTINOBACTERIA (CLASS); EUKARYOTA; FUNGI; MAMMALIA; PENICILLIUM; STREPTOMYCES;

EID: 33847067877     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2006.03135.x     Document Type: Article

References (22)

1. Andrews, P.D. and Stark, M.J.R. (2000) Type 1 protein phosphatase is required for maintenance of cell wall integrity, morphogenesis and cell cycle progression in Saccharomyces cerevisiae. J Cell Biol 113, 507-520.
2. Barford, D., Das, A.K. and Egloff, M.P. (1998) The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27, 133-164.
3. Burke, D., Dawson, D. and Stearns, T. (2000) Methods in Yeast Genetics. A Cold Spring Harbor Laboratory Course Manual. New York: Cold Spring Harbor Laboratory Press.
4. Chae, W.J., Choi, J.M., Yang, J.J. and Lee, S.K. (2004) T cellspecific immunosuppression using tautomycetin or PTDconjugated protein drugs. Yonsei Med J 45, 978-990.
5. Cheng, X.C., Kihara, T., Ying, X., Uramoto, M., Osada, H., Kusakabe, H., Wang, B.N., Kobayashi, Y. et al. (1989) A new antibiotic, tautomycetin. J Antibiot (Tokyo) 42, 141-144.
6. Evans, D.R.H. and Stark, M.J.R. (1997) Mutations in the Saccharomyces cerevisiae type 2A protein phosphatase catalytic subunit reveal roles in cell wall integrity, actin cytoskeleton organization and mitosis. Genetics 145, 227-241.
7. Giaever, G., Shoemaker, D.D., Jones, T.W., Liang, H., Winzeler, E.A., Astromoff, A. and Davis, R.W. (1999) Genomic profiling of drug sensitivities via induced haploinsufficiency. Nat Genet 21, 278-283.
8. Han, D.J., Jeong, Y.L., Wee, Y.M., Lee, A.Y., Lee, H.K., Ha, J.C., Lee, S.K. and Kim, S.C. (2003) Tautomycetin as a novel immunosuppressant in transplantation. Elsevier Science, Transplan Proc 35, 547.
9. Heinisch, J.J., Lorberg, A., Schmitz, H.-P. and Jacoby, J.J. (1999) The protein kinase C-mediated MAP kinase pathway involved in the maintenance of cell integrity in Saccharomyces cerevisiae. Mol Microbiol 32, 671-680.
10. Lo, C.W., Lai, N.S., Cheah, H.Y., Wong, N.K.I. and Ho, C.C. (2001) Actinomycetes isolated from soil samples from the Crocker Range Sabah. In Crocker Range National Park Sabah Vol 1, Natural Ecosystem and Species Component ed. Ismail, G. and Ali, L. pp. 259-267. London: Asean Acad Press.
11. MacKintosh, C. and Moorhead, G. (1999) Assay and purification of protein (serine/threonine) phosphatases. In Protein Phosphorylation, A Practical Approach, 2nd edn. ed. Hardie, D.G. pp. 153-181. New York: Oxford University Press.
12. Madeo, F., Fröhlich, E. and Frodie;hlich, K.U. (1997) A yeast mutant showing diagnostic markers of early and late apoptosis. J Cell Biol 139, 729-734.
13. McCluskey, A., Sim, A.T.R. and Sakoff, J.A. (2002) Serinethreonine protein phosphatase inhibitors: development of potential therapeutic strategies. J Med Chem 45, 1151- 75.
14. Mitsuhashi, S., Matsuura, N., Ubukata, M., Oikawa, H., Shima, H. and Kikuchi, K. (2001) Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. Biochem Biophys Res Commun 287, 328-331.
15. Mitsuhashi, S., Shima, H., Tanuma, N., Matsuura, N., Takekawa, M., Urano, T., Kataoka, T., Ubukata, M. et al. (2003) Usage of tautomycetin, a novel inhibitor of protein phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo. J Biol Chem 278, 82-88.
16. Nonomura, H. and Hayakawa, M. (1988) New methods for the selective isolation of soil actinomycetes. In Biology of Actinomycetes '88 ed. Okami, Y., Beppu, T. and Ogawara, H. pp. 288-293. Tokyo: Japan Scientific Societies Press.
17. Ogata, W.N. (1962) Preservation of Neurospora stock cultures with anhydrous silica gel. Neurospora Newsletter 1.
18. Pirouz, T., Karbasian, M.A. and Goodfellow, M. (1999) Isolation of some aerobic actinomycetes species from the soil of Zahedan County, south-east of Iran. Iran J Med Sci 24, 65-67.
19. Skoog, D.A., West, D.M. and Holler, F.J. (1994) Analytical Chemistry: An Introduction, 6th edn. Florida: Saunders College Publishing.
20. Stark, M.J.R. (2004) Protein phosphorylation. In The Metabolism and Molecular Physiology of the Yeast Saccharomyces cerevisiae ed. Dickinson, J.R. and Schweizer, M. pp. 284-375. London: CRC Press.
21. Vandré, D.D. and Wills, V.L. (1992) Inhibition of mitosis by okadaic acid: possible involvement of a protein phosphatase 2A in the transition from metaphase to anaphase. J Cell Sci 101, 79-91.
22. Voo, L.Y., Lai, N.S., Daim, S., Lo, C.W., Chung, Y.T., Moh, M.H. and Ho, C.C. (2003) Screening for inhibitors against eukaryotic signal transduction from actinomycetes and fungi from limestone hills, Tabin and caves, Sapulut. In Tabin Limestone Scientific Expedition 2000 ed. Mohamed, M., Schilthuizen, M. and Andau, M. pp. 149-156. Kota Kinabalu: Universiti Malaysia Sabah.